[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Trojanowska, 2008 - Google Patents

Role of PDGF in fibrotic diseases and systemic sclerosis

Trojanowska, 2008

View HTML
Document ID
17745463219103775753
Author
Trojanowska M
Publication year
Publication venue
Rheumatology

External Links

Snippet

PDGF functions as a primary mitogen and chemoattractant for cells of mesenchymal origin. Members of the PDGF family play an important role during embryonic development and contribute to the maintenance of connective tissue in adults. Deregulation of PDGF …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Trojanowska Role of PDGF in fibrotic diseases and systemic sclerosis
Mousa et al. Proangiogenesis action of the thyroid hormone analog 3, 5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated
Thamotharan et al. Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line
Carlson et al. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice
Dow et al. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions
Ota et al. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation
Laurén et al. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?
Zhang et al. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy
Sierra-Honigmann et al. Biological action of leptin as an angiogenic factor
Chen et al. PECAM-1 is necessary for flow-induced vascular remodeling
Wells V. TGF-β signaling pathways
Ricupero et al. Regulation of connective tissue growth factor expression by prostaglandin E2
Short et al. Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts
Chang et al. Pericytes modulate endothelial sprouting
Smith et al. Biology of the renal pericyte
Stevens et al. Modulation of receptor tyrosine kinase activity through alternative splicing of ligands and receptors in the VEGF-A/VEGFR axis
Karkkainen et al. Molecular regulation of lymphangiogenesis and targets for tissue oedema
He et al. Loureirin B inhibits hypertrophic scar formation via inhibition of the TGF-β1-ERK/JNK pathway
Okazaki et al. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice
Stannard et al. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-α
Muradashvili et al. Fibrinogen-induced increased pial venular permeability in mice
Pietrangelo Molecular insights into the pathogenesis of hereditary haemochromatosis
Asashima et al. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris
Ström et al. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration
Mezzano et al. Gremlin and renal diseases: ready to jump the fence to clinical utility?